B7-33 exhibits potent anti-fibrotic effects. It is under active research and investigation to reduce fibrosis in acute and chronic diseases like heart failure, lung inflammation, kidney, and more.
In animal studies, B7-33 has reduced fibrosis by roughly 50%, leading to prolonged survival following injury and offering the first new means of treating heart failure in 20 years.
It has been shown to reduce excessive scar formation following cardiac injury. It has also shown promise in the treatment of certain vascular disorders and preeclampsia of pregnancy.
 
Quantity: 10 units 
Unit Size: 10mg 
 
All products we sell are strictly for research use only.